BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18259945)

  • 21. [Inverse correlation of S100A4 and E-cad protein expression and their clinical significance in non-small cell lung cancer].
    Qi RX; Xu XY
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):681-4. PubMed ID: 18246798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes A and B colon cancer patients undergoing potentially curative surgery.
    Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; Romano C; Vollaro M; Agostini B; Pignatelli C; De Vita F
    Dis Colon Rectum; 2004 Nov; 47(11):1904-14. PubMed ID: 15622584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlations of S100A4 protein expression to invasion and metastasis of non-small cell lung cancer].
    Chen XL; Zhang WG; Chen XY; Sun ZM; Liu SH
    Ai Zheng; 2006 Sep; 25(9):1134-7. PubMed ID: 16965657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
    Rudland PS; Platt-Higgins A; Renshaw C; West CR; Winstanley JH; Robertson L; Barraclough R
    Cancer Res; 2000 Mar; 60(6):1595-603. PubMed ID: 10749128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation and expression of p53, HER-2, vascular endothelial growth factor (VEGF), and e-cadherin in a high-risk breast-cancer population.
    Howard EM; Lau SK; Lyles RH; Birdsong GG; Tadros TS; Umbreit JN; Kochhar R
    Int J Clin Oncol; 2004 Jun; 9(3):154-60. PubMed ID: 15221598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Factors of Prostate Cancer in Tunisian Men: Immunohistochemical Study.
    Missaoui N; Abdelkarim SB; Mokni M; Hmissa S
    Asian Pac J Cancer Prev; 2016; 17(5):2655. PubMed ID: 27268646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.
    Boye K; Jacob H; Frikstad KA; Nesland JM; Maelandsmo GM; Dahl O; Nesbakken A; Flatmark K
    Cancer Med; 2016 Aug; 5(8):1840-9. PubMed ID: 27273130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of protein S100A4 is a predictor of recurrence in colorectal cancer.
    Kwak JM; Lee HJ; Kim SH; Kim HK; Mok YJ; Park YT; Choi JS; Moon HY
    World J Gastroenterol; 2010 Aug; 16(31):3897-904. PubMed ID: 20712050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nuclear expression of S100A4 is associated with lymph node metastasis in gastric carcinoma].
    Zhong XY; Zhang LH; Jia SQ; Shi T; DU H; Hu Y; Zhang GG; Lu AP; Li JY; Ji JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):454-7. PubMed ID: 17851788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of expression of Kit67, p53, TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy.
    Zha Y; Cun Y; Zhang Q; Li Y; Tan J
    Hepatogastroenterology; 2012; 59(117):1327-32. PubMed ID: 22534478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
    Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
    Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.
    Terashima M; Kitada K; Ochiai A; Ichikawa W; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M;
    Clin Cancer Res; 2012 Nov; 18(21):5992-6000. PubMed ID: 22977193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
    Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
    Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
    Nakamura J; Kitajima Y; Kai K; Hashiguchi K; Hiraki M; Noshiro H; Miyazaki K
    Int J Cancer; 2010 Sep; 127(5):1158-71. PubMed ID: 20020496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
    Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
    J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.
    Hussein S; Mosaad H; Rashed HE; Ahmed S; Ragab A; Ismail EI
    Mol Biol Rep; 2017 Aug; 44(4):365-377. PubMed ID: 28808805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear S100A4 is a novel prognostic marker in colorectal cancer.
    Boye K; Nesland JM; Sandstad B; Mælandsmo GM; Flatmark K
    Eur J Cancer; 2010 Nov; 46(16):2919-25. PubMed ID: 20719498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between expression of S100A4 and VEGF-C, and lymph node metastasis and prognosis in gastric carcinoma.
    Feng LZ; Zheng XY; Zhou LX; Fu B; Yu YW; Lu SC; Cao NS
    J Int Med Res; 2011; 39(4):1333-43. PubMed ID: 21986134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.